Browse by Person

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Number of items: 29.

Fennell, D.A., Danson, S., Woll, P.J. et al. (9 more authors) (2020) Ganetespib in combination with pemetrexed-platinum chemotherapy in patients with pleural Mesothelioma (MESO-02) : a phase Ib trial. Clinical Cancer Research. ISSN 1078-0432

Lee, S.M., Upadhyay, S., Lewanski, C. et al. (11 more authors) (2019) The clinical role of VeriStrat testing in patients with advanced non–small cell lung cancer considered unfit for first-line platinum-based chemotherapy. European Journal of Cancer, 120. pp. 86-96. ISSN 0959-8049

Young, R.J. and Woll, P.J. (2017) Anti-angiogenic therapies for the treatment of angiosarcoma: a clinical update. Memo - Magazine of European Medical Oncology. pp. 1-4. ISSN 1865-5041

Seddon, B., Strauss, S.J., Whelan, J. et al. (16 more authors) (2017) Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled phase 3 trial. The Lancet Oncology, 18 (10). pp. 1397-1410. ISSN 1470-2045

Ferry, D., Billingham, L., Jarrett, H. et al. (16 more authors) (2017) Carboplatin versus two doses of cisplatin in combination with gemcitabine in the treatment of advanced non-small-cell lung cancer: Results from a British Thoracic Oncology Group randomised phase III trial. European Journal of Cancer, 83. pp. 302-312. ISSN 0959-8049

Lebret, T., Casas, A., Cavo, M. et al. (5 more authors) (2017) The use of bisphosphonates in the management of bone involvement from solid tumours and haematological malignancies - a European survey. European Journal of Cancer Care, 26 (4). e12490. ISSN 0961-5423

Faivre-Finn, C., Snee, M., Ashcroft, L. et al. (17 more authors) (2017) Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial. The Lancet Oncology. ISSN 1470-2045

Arriola, E., Wheater, M., Galea, I. et al. (13 more authors) (2016) Outcome and biomarker analysis from a multi-centre phase 2 study of ipilimumab in combination with carboplatin and etoposide (ICE) as first line therapy for extensive stage small cell lung cancer. Journal of Thoracic Oncology, 11 (9). pp. 1511-1521. ISSN 1556-0864

Shah, M.H., Lorigan, P., O'Brien, M.E. et al. (5 more authors) (2016) Phase I study of IMGN901, a CD56-targeting antibody-drug conjugate, in patients with CD56-positive solid tumors. Investigational New Drugs, 34 (3). pp. 290-299. ISSN 0167-6997

Young, R.J. and Woll, P.J. (2016) Eribulin in soft-tissue sarcoma. Lancet, 387 (10028). pp. 1594-1596. ISSN 0140-6736

Macbeth, F., Noble, S., Evans, J. et al. (13 more authors) (2016) Randomized Phase III Trial of Standard Therapy Plus Low Molecular Weight Heparin in Patients With Lung Cancer: FRAGMATIC Trial. Journal of Clinical Oncology, 34 (5). pp. 488-494. ISSN 0732-183X

Danson, S.J., Rowland, C., Rowe, R. et al. (7 more authors) (2015) The relationship between smoking and quality of life in advanced lung cancer patients: a prospective longitudinal study. Supportive Care in Cancer. ISSN 0941-4355

O'Brien, M.E.R., Gaafar, R., Hasan, B. et al. (12 more authors) (2015) Maintenance pazopanib versus placebo in Non-Small Cell Lung Cancer patients non-progressive after first line chemotherapy: A double blind randomised phase III study of the lung cancer group, EORTC 08092 (EudraCT: 2010-018566-23, NCT01208064). European Journal of Cancer, 51 (12). pp. 1511-1528. ISSN 0959-8049

Zhang, L.R., Morgenstern, H., Greenland, S. et al. (9 more authors) (2015) Cannabis smoking and lung cancer risk: Pooled analysis in the International Lung Cancer Consortium. International Journal of Cancer, 136 (4). pp. 894-903. ISSN 0020-7136

Cote, M.L., Liu, M., Bonassi, S. et al. (56 more authors) (2012) Increased risk of lung cancer in individuals with a family history of the disease: A pooled analysis from the International Lung Cancer Consortium. European Journal of Cancer, 48 (13). pp. 1957-1968. ISSN 0959-8049

Young, R.J., Tin, A.W., Brown, N.J. et al. (3 more authors) (2012) Analysis of circulating angiogenic biomarkers from patients in two phase III trials in lung cancer of chemotherapy alone or chemotherapy and thalidomide. British Journal of Cancer , 106 (6). 1153 - 1159. ISSN 0007-0920

Xue, X.Y., Teare, M.D., Holen, I. et al. (2 more authors) (2009) Optimizing the yield and utility of circulating cell-free DNA from plasma and serum. Clinica Chimica Acta, 404 (2). pp. 100-104. ISSN 0009-8981

Din, O.S. and Woll, P.J. (2008) Treatment of gastrointestinal stromal tumor: focus on imatinib mesylate. Therapeutics and Clinical Risk Management, 4 (1). pp. 149-162. ISSN 1176-6336

Gerrand, C.H., Billingham, L.J., Woll, P.J. et al. (1 more author) (2007) Follow up after Primary Treatment of Soft Tissue Sarcoma: A Survey of Current Practice in the United Kingdom. Sarcoma, 2007. 34128. ISSN 1357-714X

Zhu, Y.M., Bagstaff, S.M. and Woll, P.J. (2006) Production and upregulation of granulocyte chemotactic protein-2/CXCL6 by IL-1 beta and hypoxia in small cell lung cancer. British Journal of Cancer, 94 (12). pp. 1936-1941. ISSN 0007-0920

McTiernan, A., Whelan, J., Leahy, M. et al. (1 more author) (2006) A Phase II Nonrandomised Open-Label Study of Liposomal Daunorubicin (DaunoXome) in Advanced Soft Tissue Sarcoma. Sarcoma, 2006. 41080. ISSN 1357-714X

Zekri, J.M., Robinson, M.H. and Woll, P.J. (2006) Relative hypocalcaemia and muscle cramps in patients receiving imatinib for gastrointestinal stromal tumour. Sarcoma, 2006. 48948. ISSN 1357-714X

Zhu, Y.M., Webster, S.J., Flower, D. et al. (1 more author) (2004) Interleukin-8/CXCL8 is a growth factor for human lung cancer cells. British Journal of Cancer, 91 (11). pp. 1970-1976. ISSN 0007-0920

Coulson, J.M., Stanley, J. and Woll, P.J. (1999) Tumour-specific arginine vasopressin promoter activation in small-cell lung cancer. British Journal of Cancer, 80 (12). pp. 1935-1944. ISSN 0007-0920

Taylor, G.M., Gokhale, D.A., Crowther, D. et al. (5 more authors) (1999) Further investigation of the role of HLA-DPB1 in adult Hodgkin's disease (HD) suggests an influence on susceptibility to different HD subtypes. British Journal of Cancer, 80 (9). 1405 - 1411. ISSN 0007-0920

Woll, P.J., Basser, R., LeChevalier, T. et al. (6 more authors) (1997) Phase II trial of raltitrexed ('Tomudex') in advanced small-cell lung cancer. British Journal of Cancer, 76 (2). 264 - 265. ISSN 0007-0920

Woll, P.J., Crowther, D., Johnson, P.W.M. et al. (5 more authors) (1995) Phase-II trial of temozolomide in low-grade non-hodgkins-lymphoma. British Journal of Cancer, 72 (1). 183 - 184. ISSN 0007-0920

Prendiville, J., Crowther, D., Thatcher, N. et al. (8 more authors) (1993) A phase-I study of intravenous bryostatin-1 in patients with advanced cancer. British Journal of Cancer, 68 (2). 418 - 424. ISSN 0007-0920

Woll, P.J. and Rozengurt, E. (1988) Bombesin and bombesin antagonists: Studies in Swiss 3T3 cells and human small cell lung cancer. British Journal of Cancer, 57. pp. 579-586. ISSN 0007-0920

This list was generated on Mon Aug 3 00:30:08 2020 BST.